Finance

Lists
Why is TNYA up 4,58%?
Dive Deeper
TNYA:NASDAQ
Tenaya Therapeutics Inc
0,41 USD
+4,58%
(+0,018) 1D
0,42 USD
+4,06% (+0,017)
Pre-market
Closed: 15-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TNYA...
Open
0,39 USD
High
0,43 USD
Low
0,39 USD
Mkt. cap
91,75 млн
Avg. vol.
3,29 млн
Volume
38,20 миң
52-wk high
2,02 USD
52-wk low
0,36 USD
EPS
-0,53 USD
Beta
2,87
Shares outstanding
224,23 млн
No. of employees
70
Open
0,39 USD
High
0,43 USD
Low
0,39 USD
Mkt. cap
91,75 млн
Avg. vol.
3,29 млн
Volume
38,20 миң
52-wk high
2,02 USD
52-wk low
0,36 USD
EPS
-0,53 USD
Beta
2,87
Shares outstanding
224,23 млн
No. of employees
70
News stories
From web sources and news partners
About Tenaya Therapeutics Inc
CEO-
Employees70
Founded2016
HeadquartersЮг Сан Франциско, Калифорния, Америка Кошмо Штаттары
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to TNYA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for TNYA in the last 3 months.
Highest
Current 0,41 USD
40,00 USD (+9 694,32%)
Average
13,00 USD (+3 083,15%)
Lowest
3,00 USD (+634,57%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
3,00 USD
+634,6%
10/05/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
5,00 USD
+1 124,3%
08/06/2026
Cory Jubinville, PhD
LifeSci Capital
Buy
Maintained
4,00 USD
+879,4%
08/06/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
40,00 USD
+9 694,3%
08/06/2026
Sami Corwin
William Blair
Buy
Maintained
-
-
08/06/2026
Andy Hsieh
William Blair
Buy
Maintained
-
-
07/29/2026
Michael Ulz
Morgan Stanley
Buy
Reiterated
2,00 USD
+389,7%
06/03/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
8,00 USD
+1 858,9%
05/15/2026
Last report
2026-ж., 5-авг.
Fiscal period
Q2 2026
-0,09 USD / -0,07 USD
-35,90%miss
Revenue / Est. (USD)
1,11 млн / 10,00 млн
-88,90%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
225,00 миң
1,11 млн
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15,36 млн
14,80 млн
14,84 млн
16,60 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,57 млн
5,98 млн
5,45 млн
5,41 млн
Operating expense
20,94 млн
20,78 млн
20,29 млн
22,01 млн
Total operating expenses
20,94 млн
20,78 млн
20,29 млн
22,01 млн
Operating income
-20,94 млн
-20,78 млн
-20,06 млн
-20,90 млн
Other non operating income
3,00 миң
25,00 миң
-
-1,37 млн
EBT including unusual items
-20,28 млн
-20,18 млн
-19,27 млн
-43,39 млн
EBT excluding unusual items
-20,28 млн
-20,18 млн
-19,27 млн
-21,57 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20,28 млн
-20,18 млн
-19,27 млн
-43,39 млн
Net profit margin
-
-
-8 565,33%
-3 909,28%
Earnings per share
-0,12
-0,12
-0,09
-0,09
Interest and investment income
658,00 миң
575,00 миң
793,00 миң
697,00 миң
Interest expense
-
-
-
-
Net interest expenses
658,00 миң
575,00 миң
793,00 миң
697,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-19,07 млн
-18,95 млн
-18,30 млн
-19,20 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору